Navegar por autor "Ocampo Hermida, Antonio"

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients

2014- Ocampo Hermida, Antonio

Alteraciones osteoarticulares en la infeccion por el VIH. Grupo de Expertos del Plan Nacional sobre el Sida y Grupo de Estudio de Sida.

2011- Ocampo Hermida, Antonio

Anal human papillomavirus genotype distribution in hiv-infected men who have sex with men by geographical origin, age, and cytological status in a spanish cohort

2013- Ocampo Hermida, Antonio

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

2012- Aguilera Guirao, Antonio; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio; Morano Amado, Luis

Consideraciones prácticas de la anoscopia de alta resolución en pacientes infectados por el virus de la inmunodeficiencia humana

2014- Gonzalez-Carrero Fojón, Joaquín; Ocampo Hermida, Antonio; Iribarren Diaz, Gustavo Mauricio; Alonso Parada, María

Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F

2011- Mariño Callejo, Ana Isabel; Ordoñez Barrosa, Patricia; Ocampo Hermida, Antonio; Rodríguez Pérez, Raul.

Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

2014- Ocampo Hermida, Antonio

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

2015- Mariño Callejo, Ana Isabel; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio; Antela López, Antonio

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random

2015- Miralles Alvarez, María Celia; Ocampo Hermida, Antonio

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicenter cohort of HIV-infected ARV-experienced patients

2012- Ocampo Hermida, Antonio

Enfermedad de Kikuchi-Fujimoto en una portadora del VIH

2013- Ocampo Hermida, Antonio; Amado Puentes, Alfonso; Couceiro Gianzo, José Antonio

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

2014- García, Federico; Poveda López, Eva; Jesús Pérez-Elías, María; Hernández Quero, José; Ángels Ribas, María; [et al.]

Genotypic Tropism Testing of Proviral DNA To Guide Maraviroc Initiation in Aviremic Subjects

2014- Ocampo Hermida, Antonio

HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin

2014- Ocampo Hermida, Antonio

HIV encephalitis related to the development of a discordant resistant virus in CNS

2015- Perez Rodriguez, Maria Teresa; Ocampo Hermida, Antonio; Martínez Cueto, Pedro; Sousa Dominguez, Adrián

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

2011- Castro Iglesias, Angeles; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. A Cohort Study

2020- Del Amo, Julia; Polo, Rosa; Moreno, Santiago; Díaz, Asunción; Martínez, Esteban; [et al.]

Musculoskeletal disorders in HIV-infected patients

2011- Mariño Callejo, Ana Isabel; Ocampo Hermida, Antonio

Observational epidemiological study to identify the clinical profile of na ve patients starting antiretroviral (ARV) therapy in Spain

2012- Ocampo Hermida, Antonio

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study

2015- Mariño Callejo, Ana Isabel; Ocampo Hermida, Antonio; Antela López, Antonio

Repositorio digital RUNA

Navegar por autor "Ocampo Hermida, Antonio"

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients ﻿

Alteraciones osteoarticulares en la infeccion por el VIH. Grupo de Expertos del Plan Nacional sobre el Sida y Grupo de Estudio de Sida. ﻿

Anal human papillomavirus genotype distribution in hiv-infected men who have sex with men by geographical origin, age, and cytological status in a spanish cohort ﻿

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy ﻿

Consideraciones prácticas de la anoscopia de alta resolución en pacientes infectados por el virus de la inmunodeficiencia humana ﻿

Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F ﻿

Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana ﻿

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial ﻿

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random ﻿

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicenter cohort of HIV-infected ARV-experienced patients ﻿

Enfermedad de Kikuchi-Fujimoto en una portadora del VIH ﻿

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study ﻿

Genotypic Tropism Testing of Proviral DNA To Guide Maraviroc Initiation in Aviremic Subjects ﻿

HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin ﻿

HIV encephalitis related to the development of a discordant resistant virus in CNS ﻿

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C ﻿

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. A Cohort Study ﻿

Musculoskeletal disorders in HIV-infected patients ﻿

Observational epidemiological study to identify the clinical profile of na ve patients starting antiretroviral (ARV) therapy in Spain ﻿

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study ﻿

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients

Alteraciones osteoarticulares en la infeccion por el VIH. Grupo de Expertos del Plan Nacional sobre el Sida y Grupo de Estudio de Sida.

Anal human papillomavirus genotype distribution in hiv-infected men who have sex with men by geographical origin, age, and cytological status in a spanish cohort

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Consideraciones prácticas de la anoscopia de alta resolución en pacientes infectados por el virus de la inmunodeficiencia humana

Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F

Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicenter cohort of HIV-infected ARV-experienced patients

Enfermedad de Kikuchi-Fujimoto en una portadora del VIH

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

Genotypic Tropism Testing of Proviral DNA To Guide Maraviroc Initiation in Aviremic Subjects

HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin

HIV encephalitis related to the development of a discordant resistant virus in CNS

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. A Cohort Study

Musculoskeletal disorders in HIV-infected patients

Observational epidemiological study to identify the clinical profile of na ve patients starting antiretroviral (ARV) therapy in Spain

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study